These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11424630)

  • 1. Day-to-day variability of maximum walking distance in MS patients can mislead to relevant changes in the Expanded Disability Status Scale (EDSS): average walking speed is a more constant parameter.
    Albrecht H; Wötzel C; Erasmus LP; Kleinpeter M; König N; Pöllmann W
    Mult Scler; 2001 Apr; 7(2):105-9. PubMed ID: 11424630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can we trust self-reported walking distance when determining EDSS scores in patients with multiple sclerosis? The Danish MS hospitals rehabilitation study.
    Skjerbæk AG; Boesen F; Petersen T; Rasmussen PV; Stenager E; Nørgaard M; Feys P; Kjeldgaard-Jørgensen ML; Hvid LG; Dalgas U
    Mult Scler; 2019 Oct; 25(12):1653-1660. PubMed ID: 30124106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of fatigability on Expanded Disability Status Scale components in multiple sclerosis.
    Dujmović I; Demetz S; Millonig A; Deisenhammer F
    Srp Arh Celok Lek; 2016; 144(5-6):262-5. PubMed ID: 29648741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported maximum walking distance in persons with MS may affect the EDSS.
    Berger W; Payne MWC; Morrow SA
    J Neurol Sci; 2017 Aug; 379():77-80. PubMed ID: 28716284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximum walking speed in multiple sclerosis assessed with visual perceptive computing.
    Grobelny A; Behrens JR; Mertens S; Otte K; Mansow-Model S; Krüger T; Gusho E; Bellmann-Strobl J; Paul F; Brandt AU; Schmitz-Hübsch T
    PLoS One; 2017; 12(12):e0189281. PubMed ID: 29244874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performed and perceived walking ability in relation to the Expanded Disability Status Scale in persons with multiple sclerosis.
    Langeskov-Christensen D; Feys P; Baert I; Riemenschneider M; Stenager E; Dalgas U
    J Neurol Sci; 2017 Nov; 382():131-136. PubMed ID: 29111007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Walking function in clinical monitoring of multiple sclerosis by telemedicine.
    Sola-Valls N; Blanco Y; Sepúlveda M; Llufriu S; Martínez-Lapiscina EH; La Puma D; Graus F; Villoslada P; Saiz A
    J Neurol; 2015 Jul; 262(7):1706-13. PubMed ID: 25957639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set.
    Gijbels D; Dalgas U; Romberg A; de Groot V; Bethoux F; Vaney C; Gebara B; Medina CS; Maamâgi H; Rasova K; de Noordhout BM; Knuts K; Feys P
    Mult Scler; 2012 Mar; 18(3):364-71. PubMed ID: 21952098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Walking capacities in multiple sclerosis measured by global positioning system odometer.
    Créange A; Serre I; Levasseur M; Audry D; Nineb A; Boërio D; Moreau T; Maison P;
    Mult Scler; 2007 Mar; 13(2):220-3. PubMed ID: 17439888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smart watch, smarter EDSS: Improving disability assessment in multiple sclerosis clinical practice.
    Dalla-Costa G; Radaelli M; Maida S; Sangalli F; Colombo B; Moiola L; Comi G; Martinelli V
    J Neurol Sci; 2017 Dec; 383():166-168. PubMed ID: 29246607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine.
    Hobart J; Ziemssen T; Feys P; Linnebank M; Goodman AD; Farrell R; Hupperts R; Blight AR; Englishby V; McNeill M; Chang I; Lima G; Elkins J;
    CNS Drugs; 2019 Jan; 33(1):61-79. PubMed ID: 30535670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Within-day variability on short and long walking tests in persons with multiple sclerosis.
    Feys P; Bibby B; Romberg A; Santoyo C; Gebara B; de Noordhout BM; Knuts K; Bethoux F; Skjerbæk A; Jensen E; Baert I; Vaney C; de Groot V; Dalgas U
    J Neurol Sci; 2014 Mar; 338(1-2):183-7. PubMed ID: 24439144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Continuous Assessment of Step Count by Remote Monitoring With Disability Progression Among Adults With Multiple Sclerosis.
    Block VJ; Bove R; Zhao C; Garcha P; Graves J; Romeo AR; Green AJ; Allen DD; Hollenbach JA; Olgin JE; Marcus GM; Pletcher MJ; Cree BAC; Gelfand JM
    JAMA Netw Open; 2019 Mar; 2(3):e190570. PubMed ID: 30874777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gait variability across the disability spectrum in people with multiple sclerosis.
    Kalron A
    J Neurol Sci; 2016 Feb; 361():1-6. PubMed ID: 26810506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.
    Rabadi MH; Vincent AS
    Disabil Rehabil; 2013; 35(22):1877-84. PubMed ID: 23600712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients.
    Phan-Ba R; Calay P; Grodent P; Delrue G; Lommers E; Delvaux V; Moonen G; Nagels G; Belachew S
    NeuroRehabilitation; 2012; 30(4):261-6. PubMed ID: 22672939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis.
    Phan-Ba R; Pace A; Calay P; Grodent P; Douchamps F; Hyde R; Hotermans C; Delvaux V; Hansen I; Moonen G; Belachew S
    Neurorehabil Neural Repair; 2011 Sep; 25(7):672-9. PubMed ID: 21436388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Composite end points to assess delay of disability progression by MS treatments.
    Zhang J; Waubant E; Cutter G; Wolinsky J; Leppert D
    Mult Scler; 2014 Oct; 20(11):1494-501. PubMed ID: 24675040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robotic-assisted step training (lokomat) not superior to equal intensity of over-ground rehabilitation in patients with multiple sclerosis.
    Vaney C; Gattlen B; Lugon-Moulin V; Meichtry A; Hausammann R; Foinant D; Anchisi-Bellwald AM; Palaci C; Hilfiker R
    Neurorehabil Neural Repair; 2012; 26(3):212-21. PubMed ID: 22140197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness of the Multiple Sclerosis Impairment Scale in comparison with the Expanded Disability Status Scale.
    Ravnborg M; Blinkenberg M; Sellebjerg F; Ballegaard M; Larsen SH; Sørensen PS
    Mult Scler; 2005 Feb; 11(1):81-4. PubMed ID: 15732271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.